28 April 2022
Top hires for VC & PE portfolio companies Q1-2022
Search Highlights
Recent top global hires for Venture Capital and Private Equity backed companies, covering a broad range of disciplines and sectors across Life Sciences, Health, and Tech.
This quarter’s successful placements include:
| Function | Focus area | Location |
|---|---|---|
| CEO | Surgical robotics | Switzerland |
| President US | Immuno-oncology | China |
| Chief Scientific Officer | Oncology | US |
| Chief Medical Officer | Regenerative medicine | US |
| Chief Medical Officer | Oncology and gastrointestinal diseases | China |
| Chief Commercial Officer | DNA-based diagnostics | Sweden |
| Chief Operating Officer | Oncology | US |
| Chief Financial Officer | AI-enabled femtech | Ireland |
| Head of Chemistry | Precision therapeutics | UK |
| Head of Sales Americas | AI-enabled diagnostics | Nordics |
| VP Clinical Development | Precision biotherapeutics | Singapore |
| VP General Manager Pharma Services | Molecular diagnostics | US |
| VP Marketing & Communications | Rapid diagnostics | Belgium |
| Chair | RNA-based therapeutics | Germany |
| Chair | Drug discovery services | UK |
| Partner | Transatlantic life sciences investor | UK |
Newly opened projects include:
| Function | Focus area | Location |
|---|---|---|
| CEO | Immuno-oncology | Belgium |
| Chief Development Officer | Novel gene therapies | Spain |
| Chief Medical Officer | Age-related diseases | US |
| Chief Medical Officer | Digital therapeutics | Sweden |
| Chief Scientific Officer | Cell therapies | US |
| Chief Commercial Officer | Clinical research organisation | US |
| VP Business Development & Strategy | AI for drug discovery | China |
| Head of Medicinal Chemistry | Discovery tools | UK |
| Head of CMC | Bispecific antibodies & oncology | Switzerland |
| Head of Biology | Radiopharmaceuticals | Germany |
| Commercial Head Europe | Cloud-based neuro-diagnostics | Nordics |
| Director Global Remote Care | Medical devices | France |
| Chair | Oncology | Finland/ US |
| Board Director | Gene therapies | Netherlands |
Related
-
Events
AESC Global Summit on Leadership
17 November 2025 – 18 November 2025
-
Company News
LSX World Congress conference with Justine McIlroy, Client Partner
12 May 2023
-
Thought Leadership
Five Shifts to Digital Personalized Healthcare
10 May 2023
-
Company News
Digital Health UK CEO and Commercial Leaders Breakfast
28 March 2023